Diskussionsleiter: W.-K. Kim (Bad Nauheim), H. Strömer (Würzburg)
(P2002) | Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions | |
B. Al-Kassou, J. Shamekhi, K. Feldmann, J. Gillrath, J. Germeroth, M. Weber, A. Sedaghat, E. Grube, G. Nickenig, N. Werner, J.-M. Sinning (Bonn) | ||
(P2003) | Herzklappenerkrankungen: Wie aufgeklärt ist die deutsche Bevölkerung – Wo stehen wir 2017? | |
L. Gaede, J. Blumenstein, C. Liebetrau, O. Dörr, O. Husser, A. Elsässer, H. Nef, S. Achenbach, H. Möllmann (Dortmund, Bad Nauheim, Gießen, Oldenburg, Erlangen) | ||
(P2004) | Developments in Aortic valve surgery in 17 years -A single Center perspective | |
S. Tugtekin, U. Kappert, M. Wilbring (Dresden) | ||
(P2005) | Heart Valve Disease Awareness Survey 2017: What did we achieve since 2015? | |
L. Gaede, L. Aarberge, B. G. Brandon Bravo, P. Macarthy, F. Musumeci, J. L. Zamorano, H. Möllmann (Dortmund; Oslo, NO; Zwolle, NL; London, UK; Rome, IT; Madrid, ES) | ||
(P2006) | Discarding the obesity paradox? – Obesity and fat tissue deposits affect TAVR outcome | |
O. Uluocak, S. Rohrbach, G. Krombach, I. Oswald, A. Böning, P. Roth, B. Niemann (Gießen) | ||
(P2007) | Impact of operator experience on TAVR patient outcome – Comparison of early versus late experience in a large single center cohort | |
S. Haussig, N. Mangner, F. Woitek, F. Schlotter, G. Stachel, S. Leontyev, P. Kiefer, H. Thiele, M. A. Borger, D. Holzhey, A. Linke (Dresden, Leipzig) |